UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063653
Receipt number R000072853
Scientific Title Effects of Aerobic Exercise on Myokine (Irisin, IL-6, and Apelin) Dynamics in Patients with Fragility Fractures
Date of disclosure of the study information 2026/11/16
Last modified on 2026/11/16 17:48:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of a Single Bout of Aerobic Exercise on the Temporal Changes in Circulating Myokines (Irisin, IL-6, and Apelin) in Patients with Fragility Fractures

Acronym

Acute Myokine Responses to Aerobic Exercise in Patients with Fragility Fractures

Scientific Title

Effects of Aerobic Exercise on Myokine (Irisin, IL-6, and Apelin) Dynamics in Patients with Fragility Fractures

Scientific Title:Acronym

Changes in Circulating Myokines After Exercise in Patients with Fragility Fractures

Region

Japan


Condition

Condition

Patients with Fragility Fractures

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to investigate the physiological responses of myokines secreted by skeletal muscle in hospitalized patients with fragility fractures following a single bout of aerobic exercise performed with appropriate safety considerations, and to examine the clinical significance of these responses.
Specifically, this study aims to: (1) evaluate the temporal changes in circulating myokine levels before exercise, immediately after exercise, and 1 hour after exercise to characterize the acute responses to a single bout of aerobic exercise; (2) examine the associations between changes in myokine levels and muscle mass; and (3) examine the associations between changes in myokine levels and physical function, thereby investigating whether myokines may serve as objective indicators reflecting physiological responses to exercise therapy and physical functional status.

Basic objectives2

Others

Basic objectives -Others

To investigate the acute physiological responses of circulating myokines (Irisin, IL-6, and Apelin) to a single bout of aerobic exercise and their associations with muscle mass and physical function in hospitalized patients with fragility fractures.

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Serum levels of Irisin, IL-6, and Apelin will be measured at three time points: before a single bout of aerobic exercise, immediately after exercise, and 1 hour after exercise. Temporal changes in these circulating myokine levels will be evaluated.

Key secondary outcomes

1. Muscle mass and body composition

Muscle mass assessed using bioelectrical impedance analysis.

Circumferences of the calf and upper arm measured at their sites of maximum girth.

2. Physical function

Functional Reach Test.

Short Physical Performance Battery.

Grip strength.

3. Other physical assessments

Lower leg edema assessed by measuring the circumference of both lower legs at 10 cm above the lateral malleolus and evaluating the side-to-side difference.

Blood pressure measured using a sphygmomanometer.

4. Associations between myokine responses and physical characteristics

Associations between changes in myokine levels and muscle mass.

Associations between changes in myokine levels and physical function.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

A single bout of aerobic exercise using a recumbent ergometer for approximately 25 minutes.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

The study will include 32 patients aged 65 years or older who are admitted to the rehabilitation ward of Aichi Medical University Medical Center between the date of research approval and December 2030, have a fragility fracture, and receive a prescription for physical or occupational therapy during hospitalization.

Key exclusion criteria

1. Patients with fractures resulting from high-energy trauma, such as traffic accidents.

2. Patients with osteoarthritis of the knee or hip that makes exercise difficult.

3. Patients taking beta-blockers.

4. Patients with an implanted cardiac pacemaker.

5.Patients with severe cardiovascular or respiratory diseases.

6. Patients with severe cognitive impairment (Mini-Mental State Examination Japanese [MMSE-J] score below 16).

7. Patients with a history of stroke.

8. Patients with neurological disorders.

9. Patients for whom exercise is contraindicated or restricted.

10. Patients with deep vein thrombosis (DVT) or suspected DVT.

Target sample size

32


Research contact person

Name of lead principal investigator

1st name Takahiro
Middle name
Last name Ogawa

Organization

Aichi Medical University Graduate School

Division name

Department of Rehabilitation Medicine

Zip code

4801195

Address

1-1 Yazako karimata, Nagakute, Aichi, Japan

TEL

09087360839

Email

katou.ayana.005.@mail.aichi-med-u.ac.jp


Public contact

Name of contact person

1st name Ayana
Middle name
Last name Kato

Organization

Aichi Medical University Graduate School

Division name

Department of Rehabilitation Medicine

Zip code

4801195

Address

1-1 Yazako karimata, Nagakute, Aichi, Japan

TEL

09087360839

Homepage URL


Email

k_flower4869@yahoo.co.jp


Sponsor or person

Institute

Aichi Medical University

Institute

Department

Personal name



Funding Source

Organization

Aichi Medical University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of Aichi Medical University School of Medicine

Address

1-1 Yazako karimata, Nagakute, Aichi, Japan

Tel

0561623311

Email

amu_ethics@aichi-med-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 12 Month 01 Day

Date of IRB

2026 Year 11 Month 18 Day

Anticipated trial start date

2026 Year 12 Month 01 Day

Last follow-up date

2030 Year 12 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 11 Month 16 Day

Last modified on

2026 Year 11 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072853